BionTech
16.11.2020
COVID-19 vaccine update: Pfizer may be the frontrunner, but Canada has hedged its bets
Pfizer and BioNTech have surprised the world, and given it hope, with the preliminary results of the Phase 3 clinical trial of their coronavirus vaccine. They announced on Nov. 9 that the early analysis of the data from the Phase 3 clinical trial, which is still ongoing, showed the… »
10.11.2020
Developments in the much needed Covid-19 vaccine
Yesterday’s announcement by Pfizer (American interests) and BionTech (German interests) created waves in the international race to find a vaccine. An early analysis of the results showed that people who received two doses of the vaccine over a period of three weeks had more than 90% fewer cases of symptomatic… »
Training Pressenza
Documentaries Catalogue
Every Sunday
In Mobilization For Assange!
In The Zone Podcast
International Campaign to Abolish Nuclear Weapons
